All In MedTech

Device Trial Radar · NCT06051942

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Last checked: Nov 20, 2026Latest source record: Jan 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

125

Actual

Start

Nov 22, 2022

Primary completion

Jul 2026

Study completion Mar 2027

Sponsor

Lead sponsor
PROCEPT BioRoboticsPublic (PRCT)
Sponsor type
Industry
First posted
Sep 25, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.

Conditions

  • Benign Prostatic Hyperplasia
  • Localized Prostate Cancer

Interventions

  • Robotic Waterjet TreatmentDevice

    The Aquablation therapy is a minimally invasive, image-guided, heat-free robotic therapy delivered by the AQUABEAM Robotic System. During Aquablation therapy, the AQUABEAM Handpiece is inserted transurethrally into the prostatic urethra. The operating physician then utilizes cystoscopy in conjunction with transrectal ultrasound (TRUS) imaging for real time visualization. The AQUABEAM Robotic System utilizes high-velocity sterile saline waterjet to resect and remove the prostate tissue according to the operating physician's treatment plan.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Clavien-Dindo Adverse Events (Percentage of Participants) Through 3 Months Post TreatmentTime frame: 3 months post-treatment

Locations

6 sites in 4 countries. Site status is shown where the registry gives one.

  • San Diego Clinical Trials

    La Mesa, California

  • Endeavour Health (NorthShore University HealthSystem)

    Glenview, Illinois

  • Potomac Urology Center

    Alexandria, Virginia

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.